PT  - JOURNAL ARTICLE
AU  - Sansao A. Pedro
AU  - Frank T. Ndjomatchoua
AU  - Peter Jentsch
AU  - Jean M. Tchuenche
AU  - Madhur Anand
AU  - Chris T. Bauch
TI  - Conditions for a second wave of COVID-19 due to interactions between disease dynamics and social processes
AID  - 10.1101/2020.05.22.20110502
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.22.20110502
4099  - http://medrxiv.org/content/early/2020/05/24/2020.05.22.20110502.short
4100  - http://medrxiv.org/content/early/2020/05/24/2020.05.22.20110502.full
AB  - In May 2020, many jurisdictions around the world began lifting physical distancing restrictions against the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), giving rise to concerns about a possible second wave of coronavirus disease 2019 (COVID-19). These restrictions were imposed as a collective population response to the presence of COVID-19 in communities. However, lifting restrictions is also a population response to their socio-economic impacts, and is expected to increase COVID-19 cases, in turn. This suggests that the COVID-19 pandemic exemplifies a coupled behaviour-disease system. Here we develop a minimal mathematical model of the interaction between social support for school and workplace closure and the transmission dynamics of SARS-CoV-2. We find that a second wave of COVID-19 occurs across a broad range of plausible model input parameters, on account of instabilities generated by behaviour-disease interactions. We conclude that second waves of COVID-19–should they materialize–can be interpreted as the outcomes of nonlinear interactions between disease dynamics and population behaviour.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by NSERC Discovery Grants to MA and CTB. The funders had no role in the research or decision to publish the research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB/oversight body approval was required for this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used to generate model projections are publicly available. The model simulation code is available upon request.